Structural, kinetic, and biophysical analysis and engineering of KIT.METRNL sign...
Structural, kinetic, and biophysical analysis and engineering of KIT.METRNL signalling to boost heart tissue regeneration after myocardial infarction
KIT, a receptor tyrosine kinase, is dimerized at the cell surface by the cytokine stem cell factor (SCF) to initiate signalling pathways securing fundamental cellular processes, including hematopoiesis, gametogenesis, and melanoge...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
RTC-2016-4911-1
Desarrollo clínico de una terapia celular para reparación ca...
641K€
Cerrado
SAF2013-42528-R
NUEVAS ESTRATEGIAS EN REGENERACION CARDIACA COMBINANDO CELUL...
242K€
Cerrado
PID2019-107150RB-I00
INCAPACITACION DE LAS CELULAS ENDOGENAS DEL TEJIDO CARDIACO...
121K€
Cerrado
SAF2013-44942-R
VIAS DE SEÑALIZACION PARA DESARROLLO Y MUERTE CELULAR EN EL...
194K€
Cerrado
SAF2008-02099
CARACTERIZACION MOLECULAR Y CELULAR DE LAS POBLACIONES DE CE...
254K€
Cerrado
SAF2012-38449
MEJORANDO EL REJUVENECIMIENTO Y LA REGENERACION CARDIACA
152K€
Cerrado
Información proyecto HeartRepairKIT
Duración del proyecto: 24 meses
Fecha Inicio: 2024-03-04
Fecha Fin: 2026-03-31
Líder del proyecto
VIB VZW
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
192K€
Descripción del proyecto
KIT, a receptor tyrosine kinase, is dimerized at the cell surface by the cytokine stem cell factor (SCF) to initiate signalling pathways securing fundamental cellular processes, including hematopoiesis, gametogenesis, and melanogenesis. Impaired signalling due to KIT mutations or deficiency leads to various malignancies such as leukemia and melanoma. However, recent data have shown that KIT can also initiate signalling by binding meteorin-like protein (METRNL), triggering unrelated stimulation of heart tissue regeneration. Ischemic heart diseases are the leading cause of mortality and morbidity worldwide, with approximately 9 million annual deaths and over 180 million disability-adjusted life years lost. Therefore, revealing the molecular principles and mechanism of this completely new function of KIT gives hope for new opportunities towards novel therapies that might maximize the efficiency of heart recovery after heart disease incidence. However, the field is currently plagued by a paucity of mechanistic details and the structure-function relationship of the KIT.METRNL complex assembly. The goal of this project is to derive the structure-function landscape of the novel interaction between KIT and METRNL and to provide a blueprint for how KIT can be activated by two structurally distinct protein ligands. The gained knowledge will govern the rational engineering of METRNL towards improving its interaction with KIT to elicit intensified signalling that can lead to amplified heart tissue regeneration. This aim will be achieved by synergistically combining methods of molecular and structural biology (supervisor’s expertise), biomolecular kinetics and rational protein engineering (researcher’s experience), and single molecule biophysics (secondment). Collectively, this research endeavour will impact basic and applied cardiovascular disease research and promises to provide new possibilities for alleviating the enormous socioeconomic burden associated with these diseases.